Jul 29, 2024 / 05:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Aarti Drugs Limited Q1 FY25 earnings conference call. This conference call may contain forward-looking statements about the company which are based on beliefs, opinions, and expectations of the company as on the date of this call. These statements are not the guarantees of future performance and involve risk and uncertainties that are difficult to predict.
As a reminder, all the participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Adhish Patil, [Promoter and CEO] of Aarti Drugs Limited. Thank you and over to you.
Adhish Patil - Aarti Drugs Ltd - Chief Financial Officer, Chief Operating Officer
Good morning, everyone, and a very warm welcome on the behalf of Aarti Drugs management for the earnings conference call of Aarti Drugs for the June quarter 2024. On this call, we are joined by Mr. Harshit
Q1 2025 Aarti Drugs Ltd Earnings Call Transcript
Jul 29, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers